172 related articles for article (PubMed ID: 22058208)
21. A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia.
Yang YL; Yen CT; Pai CH; Chen HY; Yu SL; Lin CY; Hu CY; Jou ST; Lin DT; Lin SR; Lin SW
PLoS One; 2015; 10(11):e0142863. PubMed ID: 26580398
[TBL] [Abstract][Full Text] [Related]
22. TWIST2: A new candidate tumor suppressor in prostate cancer.
Zhao C; Zhang W; Zhu X; Xu Y; Yang K; Wei D; Liang S; Zhao F; Zhang Y; Chen X; Sun L; Yuan H; Shi X; Wang X; Liu M; Yang F; Wang J; Yang Z
Prostate; 2019 Oct; 79(14):1647-1657. PubMed ID: 31433071
[TBL] [Abstract][Full Text] [Related]
23. The role of DNA hypermethylation in the pathogenesis and prognosis of acute lymphoblastic leukemia.
Roman-Gomez J; Castillejo JA; Jimenez A; Barrios M; Heiniger A; Torres A
Leuk Lymphoma; 2003 Nov; 44(11):1855-64. PubMed ID: 14738136
[TBL] [Abstract][Full Text] [Related]
24. The correction of ETV6/RUNX1 translocation in acute lymphocytic leukemia cells: a new gene targeting system by homologous recombination mechanism.
Akbari M; Ebrahimabadi S; Golalipour M; Shahbazi M; Farazmandfar T
J Appl Genet; 2020 Feb; 61(1):67-73. PubMed ID: 31602594
[TBL] [Abstract][Full Text] [Related]
25. p53-independent epigenetic repression of the p21(WAF1) gene in T-cell acute lymphoblastic leukemia.
Davies C; Hogarth LA; Dietrich PA; Bachmann PS; Mackenzie KL; Hall AG; Lock RB
J Biol Chem; 2011 Oct; 286(43):37639-50. PubMed ID: 21903579
[TBL] [Abstract][Full Text] [Related]
26. The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding.
Mulero-Navarro S; Carvajal-Gonzalez JM; Herranz M; Ballestar E; Fraga MF; Ropero S; Esteller M; Fernandez-Salguero PM
Carcinogenesis; 2006 May; 27(5):1099-104. PubMed ID: 16410262
[TBL] [Abstract][Full Text] [Related]
27. Aberrant DNA methylation of key genes and Acute Lymphoblastic Leukemia.
Rahmani M; Talebi M; Hagh MF; Feizi AAH; Solali S
Biomed Pharmacother; 2018 Jan; 97():1493-1500. PubMed ID: 29793312
[TBL] [Abstract][Full Text] [Related]
28. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.
Schotte D; Lange-Turenhout EA; Stumpel DJ; Stam RW; Buijs-Gladdines JG; Meijerink JP; Pieters R; Den Boer ML
Haematologica; 2010 Oct; 95(10):1675-82. PubMed ID: 20494936
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanism of transforming growth factor-beta-mediated inhibition of growth arrest and differentiation in a myoblast cell line.
Murakami M; Ohkuma M; Nakamura M
Dev Growth Differ; 2008 Feb; 50(2):121-30. PubMed ID: 18211587
[TBL] [Abstract][Full Text] [Related]
30. [Study on abnormal expression of the p73 gene in childhood acute lymphoblastic leukemia].
Liu M; Li R; Hayashi Y; Zhu G; Guo S
Zhonghua Xue Ye Xue Za Zhi; 2002 May; 23(5):239-42. PubMed ID: 12133444
[TBL] [Abstract][Full Text] [Related]
31. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
[TBL] [Abstract][Full Text] [Related]
32. Role of the erythropoietin receptor in ETV6/RUNX1-positive acute lymphoblastic leukemia.
Inthal A; Krapf G; Beck D; Joas R; Kauer MO; Orel L; Fuka G; Mann G; Panzer-Grümayer ER
Clin Cancer Res; 2008 Nov; 14(22):7196-204. PubMed ID: 19010836
[TBL] [Abstract][Full Text] [Related]
33. Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia.
Jakobczyk H; Debaize L; Soubise B; Avner S; Rouger-Gaudichon J; Commet S; Jiang Y; Sérandour AA; Rio AG; Carroll JS; Wichmann C; Lie-A-Ling M; Lacaud G; Corcos L; Salbert G; Galibert MD; Gandemer V; Troadec MB
J Hematol Oncol; 2021 Mar; 14(1):47. PubMed ID: 33743795
[TBL] [Abstract][Full Text] [Related]
34. Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia.
Shi PJ; Xu LH; Lin KY; Weng WJ; Fang JP
J Hematol Oncol; 2016 Feb; 9():12. PubMed ID: 26892465
[TBL] [Abstract][Full Text] [Related]
35. Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting.
Schafer E; Irizarry R; Negi S; McIntyre E; Small D; Figueroa ME; Melnick A; Brown P
Blood; 2010 Jun; 115(23):4798-809. PubMed ID: 20215641
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance.
Bram EE; Stark M; Raz S; Assaraf YG
Neoplasia; 2009 Dec; 11(12):1359-70. PubMed ID: 20019844
[TBL] [Abstract][Full Text] [Related]
37. Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndrome.
Kubota Y; Uryu K; Ito T; Seki M; Kawai T; Isobe T; Kumagai T; Toki T; Yoshida K; Suzuki H; Kataoka K; Shiraishi Y; Chiba K; Tanaka H; Ohki K; Kiyokawa N; Kagawa J; Miyano S; Oka A; Hayashi Y; Ogawa S; Terui K; Sato A; Hata K; Ito E; Takita J
Cancer Sci; 2019 Oct; 110(10):3358-3367. PubMed ID: 31385395
[TBL] [Abstract][Full Text] [Related]
38. Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia.
Frost BM; Forestier E; Gustafsson G; Nygren P; Hellebostad M; Jonsson OG; Kanerva J; Schmiegelow K; Larsson R; Lönnerholm G
Blood; 2004 Oct; 104(8):2452-7. PubMed ID: 15217836
[TBL] [Abstract][Full Text] [Related]
39. Twist2 regulates CD7 expression and galectin-1-induced apoptosis in mature T-cells.
Koh HS; Lee C; Lee KS; Park EJ; Seong RH; Hong S; Jeon SH
Mol Cells; 2009 Dec; 28(6):553-8. PubMed ID: 19937140
[TBL] [Abstract][Full Text] [Related]
40. Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients.
Tao YF; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Xu LX; Li ZH; Wang NN; Du XJ; Sun LC; Zhao H; Fang F; Su GH; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
Int J Mol Med; 2014 Dec; 34(6):1505-15. PubMed ID: 25319049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
